r CASC Stock Quote - Cascadian Therapeutics Inc. Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Cascadian Therapeutics Inc.
(NASDAQ : CASC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
BZUNBaozun Inc Sponsored ADR Class A
-0.77%58.051.7%$174.70m
ZZillow Group, Inc. Class C
0.27%56.1510.8%$138.45m
FLTFleetCor Technologies, Inc.
-0.12%202.133.3%$132.38m
ITGartner, Inc.
-0.51%130.632.4%$119.53m
EFXEquifax Inc.
0.46%115.192.0%$97.66m
XRXXerox Corporation
-0.71%27.915.3%$88.98m
CPRTCopart, Inc.
2.92%54.254.5%$86.77m
ULTIUltimate Software Group, Inc.
0.47%265.4710.1%$75.80m
CTASCintas Corporation
-0.45%180.844.5%$70.79m
TRUTransUnion
-0.13%68.390.9%$60.54m
ETSYEtsy, Inc.
3.19%30.447.9%$58.22m
CDKCDK Global Inc
-0.45%63.762.2%$54.34m
RLGYRealogy Holdings Corp.
-0.37%23.983.4%$49.06m
MDSOMedidata Solutions, Inc.
-1.00%75.337.7%$48.26m
KARKAR Auction Services, Inc.
0.63%53.271.4%$47.91m

Company Profile

Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for the treatment of cancer. Its lead product candidate ONT-380, is an orally active and selective small-molecule HER2 inhibitor. It also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Seattle, WA